OneMedNet (ONMD) Investor presentation summary

Business overview

• Provides an AI-powered platform (iRWD™) that aggregates and anonymizes real-world data from over 1,750 healthcare sites, supporting innovation in drug development, medical devices, and AI research.

• Platform delivers de-identified medical imaging and electronic health records, enabling precision insights for life sciences, healthcare, and other industries like finance and retail.

• Active on five major data marketplaces and trusted by leading life sciences companies for clinical trials, regulatory submissions, and AI development.

• Repository includes over 136 million clinical exams, growing at approximately 5% annually.

Market opportunity and solutions

• Addresses challenges of data scarcity, bias, and cost by leveraging a broad provider network, smarter indexing, and AI-driven de-identification.

• Target markets include AI model development ($60B+), medical devices, and drug development ($190B R&D spend in top biotech by 2025).

• Real-world data can replace or supplement clinical trials, accelerate AI model development, and support regulatory requirements for medical devices and drugs.

• Platform provides live, longitudinal, and diverse datasets, improving research outcomes and enabling real-world impact.

Technology and platform features

• Proprietary iRWD™ platform offers on-demand, live access to curated, anonymized datasets from hospitals, clinics, and treatment centers.

• AI automates de-identification and data curation, supporting compliance and secure data sharing across industries.

• Platform supports federated search, deep indexing, and easy-to-buy subscriptions for curated datasets.

• Enables testing and upgrades on de-identified production data in finance and retail, reducing risk and improving customer experience.